Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,737,741
+$7,389,140 QoQ
Shares Held
107,678
+3551.3% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#279
of 1,408 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Engineers Gate Manager LP holds $33,272,501 across 27 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
107,678 | $7,737,741 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
18,361 | $3,094,562 | |
| 3 | LQDA |
Liquidia Corp
|
36,213 | $2,887,262 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,658 | $2,523,844 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
83,722 | $2,060,398 | |
| 6 | HLN |
Haleon plc
|
200,344 | $1,869,209 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
175,002 | $1,750,020 | |
| 8 | PAHC |
Phibro Animal Health Corp
|
52,914 | $1,661,499 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,737,741 | 107,678 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $348,601 | 2,949 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,654,055 | 140,312 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $22,421,052 | 153,233 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,057,432 | 179,913 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,525,566 | 15,339 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,978,287 | 73,518 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,594,255 | 13,278 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,433,513 | 8,269 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $19,628,698 | 116,002 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $967,676 | 5,562 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,924,290 | 57,629 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,594,105 | 21,594 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,214,810 | 15,113 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $834,279 | 5,626 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,906,831 | 16,911 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,343,119 | 70,752 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,859,020 | 7,618 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,209,686 | 6,231 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $569,329 | 3,055 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $494,802 | 3,142 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,342,370 | 8,111 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $534,145 | 3,230 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $748,238 | 5,460 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $621,167 | 5,278 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||